ThePrintPod: Antibiotic Zaynich holds promise of becoming ‘game-changer’ in fight against antimicrobial resistance

Mumbai-based Wockhardt has completed phase 3 clinical trials in nearly 400 patients. Pharma firm looking to file for regulatory approvals in India, US and other countries in 2025.